Dr. Reema Batra, MD
Claim this profileSharp Memorial Hospital
Studies Carcinoma
Studies Ductal Carcinoma
2 reported clinical trials
6 drugs studied
Area of expertise
1Carcinoma
Stage I
Stage II
2Ductal Carcinoma
Stage I
Stage II
Affiliated Hospitals
More about Reema Batra, MD
Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Reema Batra, MD has experience with
- Active Monitoring
- Surgery
- Atezolizumab
- Bevacizumab
- IPI-549
- Nab-paclitaxel
Breakdown of trials Reema Batra, MD has run
Intraductal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reema Batra, MD specialize in?
Reema Batra, MD focuses on Carcinoma and Ductal Carcinoma. In particular, much of their work with Carcinoma has involved Stage I patients, or patients who are Stage II.
Is Reema Batra, MD currently recruiting for clinical trials?
No, Reema Batra, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Reema Batra, MD has studied deeply?
Yes, Reema Batra, MD has studied treatments such as Active Monitoring, Surgery, Atezolizumab.
What is the best way to schedule an appointment with Reema Batra, MD?
Apply for one of the trials that Reema Batra, MD is conducting.
What is the office address of Reema Batra, MD?
The office of Reema Batra, MD is located at: Sharp Memorial Hospital, San Diego, California 92123 United States. This is the address for their practice at the Sharp Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.